Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1835244

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1835244

Hip Replacement Implant Market by Surgical Approach, Fixation Method, Material Pairing, Procedure Type, End User - Global Forecast 2025-2032

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Hip Replacement Implant Market is projected to grow by USD 12.75 billion at a CAGR of 7.77% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.00 billion
Estimated Year [2025] USD 7.56 billion
Forecast Year [2032] USD 12.75 billion
CAGR (%) 7.77%

A strategic orientation to the hip replacement implant sector that synthesizes clinical drivers, technological advances, and procurement realities for executives

Hip arthroplasty continues to be one of the most impactful interventions in musculoskeletal care, driven by demographic shifts, rising chronic disease burden, and evolving expectations for patient outcomes and recovery speed. Advances in implant materials and fixation techniques are converging with surgical innovation to expand treatment options for heterogeneous patient profiles, while healthcare delivery models are migrating procedures from inpatient wards to ambulatory settings. At the same time, payers and providers are imposing greater scrutiny on value, leading to a tighter coupling between clinical evidence and purchasing decisions.

Clinicians and procurement leaders are navigating a complex matrix of trade-offs that include longevity, wear performance, intraoperative efficiency, and total episode cost. Technology adoption is not monolithic; geographical and institutional differences shape uptake of robotics, navigation, and minimally invasive techniques. Regulatory frameworks and post-market surveillance expectations are also rising, creating a premium for robust clinical data and longitudinal outcomes. These forces collectively demand that manufacturers, health systems, and distributors adopt more integrated strategies that connect product development with payer engagement and provider training, ensuring that innovations translate into measurable improvements in clinical and economic outcomes.

This executive summary frames the critical dynamics that will influence competitive positioning over the near to medium term. It emphasizes the need for coordinated action across R&D, market access, and operations to respond to shifting demand patterns while sustaining regulatory compliance and clinician trust.

Compounding clinical, technological, and supply-side shifts that are redefining how hip implant innovation translates into provider adoption and commercial value

The hip implant landscape is undergoing a period of accelerated transformation as incremental improvements in materials and technique compound with disruptive digital capabilities. Material science progress-driven by innovations in ceramic composites, highly crosslinked polyethylene, and surface coatings-has extended the performance envelope of modern bearings while simultaneously altering surgeon preferences and revision profiles. Surgical technique is also evolving; minimally invasive approaches and tissue-sparing access routes are becoming more prevalent as providers seek faster recovery times and reduced length of stay. These clinical shifts have been catalyzed by enhanced imaging, intraoperative guidance, and adoption of robotics, which collectively improve implant positioning and reproducibility.

Concurrently, care delivery is adjusting to financial and logistical pressures. The expansion of ambulatory surgical centers has changed the calculus for device selection, with a premium on implants that enable predictable operative times and straightforward inventory management. Supply chain resilience has come into sharper focus, prompting OEMs to diversify sourcing and hold strategic inventories to guard against disruptions. Reimbursement models are increasingly oriented toward episode-based payments, incentivizing devices and care pathways that reduce readmissions and revisions. As a result, commercial strategies are adapting to emphasize outcome evidence, surgeon training programs, and post-market surveillance.

Taken together, these transformative shifts reinforce a cross-functional imperative: success in this sector requires integrated investments in clinical evidence generation, digital enablement for surgeons, and operational mechanisms that align product value with evolving care delivery models.

Operational and strategic implications of the 2025 United States tariff measures on sourcing, pricing strategies, and clinical access to hip implant technologies

The imposition of new tariffs by the United States in 2025 has introduced a significant inflection point for global hip implant supply dynamics and procurement strategies. Tariff measures increase landed costs for imported components and finished devices, prompting manufacturers and distributors to reassess sourcing footprints and contract structures. In response, many suppliers accelerate nearshoring initiatives, migrate critical manufacturing steps to tariff-safe jurisdictions, or reconfigure component sourcing to minimize customs exposure. These operational responses are complemented by contract renegotiations with health systems that seek greater price transparency and shared risk arrangements to mitigate increased procurement costs.

Hospitals and ambulatory centers confront trade-offs between continuity of care and cost containment. Some institutions preserve existing supplier relationships but push for volume discounts, extended warranties, or consignment models to manage working capital. Others diversify their supplier base to include domestic manufacturers or alternative material pairings that yield favorable pricing without compromising clinical outcomes. Importantly, the tariff environment has placed a premium on supply-chain visibility and classification accuracy, as tariff codes and product categorizations materially affect duty burdens.

From a strategic perspective, suppliers with flexible manufacturing footprints, vertically integrated capabilities, and established regulatory dossiers are better positioned to absorb or offset tariff-driven cost pressures. Forward-looking organizations invest in long-term supplier diversification, invest in customs and trade compliance capabilities, and collaborate with payers and providers to structure value-based purchasing arrangements that share the downside of short-term cost shocks while preserving access to clinically preferred solutions.

Segment-centric intelligence revealing differentiated clinical needs, device performance expectations, and procurement drivers across surgical, fixation, material, procedure, and end-user dimensions

Analyzing the market through detailed segmentation illuminates where clinical need, operational feasibility, and commercial opportunity intersect. Surgical approach divides into minimally invasive and traditional pathways, with the minimally invasive category further distinguishing anterior minimal and posterolateral minimal techniques, and the traditional category distinguishing anterior and posterior approaches. Each pathway introduces unique instrumentation needs, implant geometries, and perioperative protocols that influence surgeon preference and hospital inventory decisions. Minimally invasive anterior techniques, for example, often prioritize implants and instruments that facilitate muscle-sparing access and quicker rehabilitation, whereas traditional posterior approaches may favor implants with established long-term outcome data and broader compatibility with legacy instrumentation.

Fixation method segmentation-cemented, cementless, and hybrid-creates differentiated value propositions for distinct patient cohorts. Cementless systems emphasize osseointegration and modularity, often paired with advanced surface treatments to promote bone in-growth, whereas cemented options remain relevant for specific anatomical or bone-quality considerations. Material pairing segmentation spans ceramic on ceramic, ceramic on polyethylene, metal on metal, and metal on polyethylene configurations. Ceramic on ceramic further divides into alumina on alumina and zirconia on zirconia variants, while ceramic on polyethylene differentiates alumina on polyethylene and zirconia on polyethylene. Metal on metal and metal on polyethylene combinations are similarly subdivided by cobalt chrome or titanium pairings against matching or polyethylene counterparts. These material permutations affect wear behavior, squeaking risk, imaging artifact profiles, and revision strategies, influencing both clinician selection and procurement negotiations.

Procedure type segmentation separates primary from revision procedures, with the primary category subdivided into bilateral and unilateral cases and the revision category differentiated into acetabular, dual, and femoral revisions. The technical complexity, inventory requirements, and cost implications vary substantially across these procedure types, with revision cases typically necessitating expanded modularity and more specialized implants. End-user segmentation between ambulatory surgical centers and hospitals drives divergent purchasing criteria; ambulatory settings prioritize implants that support rapid throughput and predictable outcomes, while hospitals weigh broader case-mix flexibility and long-term registry data more heavily. Integrating these segmentation lenses reveals targeted pathways for product development, clinical education, and reimbursement engagement that align with each segment's distinct clinical and operational priorities.

Comparative regional dynamics that influence regulatory strategy, procurement priorities, and adoption pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in meaningful ways, creating distinct playbooks for market entry and expansion. In the Americas, a mature reimbursement ecosystem and a high penetration of ambulatory surgical centers accelerate interest in implants that reduce length of stay and support rapid recovery protocols. This region also places a strong emphasis on robust longitudinal outcomes and registries, which reinforce clinician and payer confidence in proven technologies. Regulatory engagement and payer negotiations in the Americas often prioritize real-world evidence and value-based contracting to align product adoption with fiscal accountability.

Across Europe, the Middle East & Africa, heterogeneous regulatory regimes and varying reimbursement frameworks necessitate region-specific strategies. Several European markets maintain centralized procurement mechanisms and comparative effectiveness evaluations that favor cost-effective solutions with strong clinical evidence. Middle Eastern markets are increasingly receptive to premium technologies when bundled with training and service commitments, while many African markets prioritize affordability and supply reliability. Vendors must therefore calibrate offerings to local procurement norms and invest in targeted clinical and commercial support to overcome market fragmentation.

The Asia-Pacific region is characterized by rapid volume growth, expanding surgical capacity, and divergent maturity across national health systems. Certain countries lead in local manufacturing capabilities and innovation adoption, while others are still building procedural capacity and registry infrastructure. Cost-sensitive procurement coexists with pockets of rapid adoption for advanced materials and digital surgical tools, driven by rising clinician expertise and expanding private-sector surgical facilities. These regional contrasts underscore the need for differentiated go-to-market strategies that account for regulatory complexity, local manufacturing potential, and the balance between premium and cost-effective product tiers.

Competitive dynamics and supplier playbooks that combine product innovation, clinical evidence generation, and service-led differentiation to win in a value-focused environment

The supplier ecosystem continues to evolve, with incumbents refining product breadth and emerging players carving niche positions through material innovation, modular architectures, or service-led propositions. Competitive differentiation increasingly hinges on a combination of clinical evidence, surgeon training and support, and integrated offerings that extend beyond the implant itself to include instrumentation, digital planning tools, and aftermarket services. Strategic behaviors observed across the sector include vertical integration to secure critical component supply, selective partnerships with robotics and navigation developers, and investment in clinical registry programs to reinforce safety and effectiveness claims.

Commercial models are also diversifying. Some suppliers emphasize bundled solutions and episode-based pricing, collaborating directly with providers and payers to align incentives around outcomes. Others prioritize high-touch surgeon engagement through education centers, cadaver labs, and proctoring programs to accelerate technique adoption. Distribution and logistics capabilities are a differentiator as well, particularly in regions where supply-chain reliability influences purchasing decisions. Organizations that offer predictable service levels, flexible consignment arrangements, and responsive clinical support gain a competitive edge in procurement discussions.

Success for market participants depends on balancing near-term commercial wins with long-term investments in evidence generation and clinician partnerships. Firms that combine product performance with operational excellence and demonstrable outcomes are better placed to influence formularies and secure sustained preferential use.

Practical and prioritized actions for manufacturers, providers, and distributors to strengthen resilience, accelerate adoption, and capture value amid clinical and policy shifts

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with operational resilience and payer engagement. First, diversify manufacturing and supplier relationships to reduce exposure to trade-policy volatility and ensure uninterrupted supply to high-volume centers. Establishing regional production capabilities or multi-sourcing for critical components will preserve continuity while delivering cost predictability. Second, prioritize investments in minimally invasive platforms and modular implant systems that address growing demand for faster recovery and versatile revision options. Complement product launches with comprehensive surgeon training, intraoperative planning tools, and outcomes tracking to shorten adoption cycles and build real-world evidence.

Third, engage payers proactively to develop value-based arrangements that reward outcomes and cost containment. Structure pilot programs that demonstrate reductions in length of stay, readmission rates, and revision incidence, and leverage these results to negotiate preferred-product pathways. Fourth, optimize commercial models for ambulatory surgical centers by tailoring bundles that support higher throughput, simplified instrumentation, and just-in-time supply. Fifth, enhance post-market surveillance and data analytics capabilities to detect performance trends early and to support regulatory submissions and tender processes. Finally, scenario-plan for regulatory and trade-policy changes by investing in customs expertise, tariff classification accuracy, and flexible logistics to maintain competitiveness under shifting external conditions.

Implementing these actions requires cross-functional coordination across R&D, supply chain, clinical affairs, and commercial teams, ensuring that investments in product and process translate into measurable improvements in clinical outcomes and financial performance.

Methodological transparency describing primary and secondary evidence collection, triangulation techniques, and quality controls that underpin the executive findings

The analysis draws on a rigorous mixed-methods research design combining primary stakeholder engagement with comprehensive secondary evidence synthesis. Primary inputs include structured interviews with orthopedic surgeons, hospital procurement leaders, ambulatory surgical center administrators, regulatory specialists, and senior commercial executives to capture firsthand perspectives on clinical preferences, purchasing dynamics, and operational challenges. These qualitative insights are complemented by a review of peer-reviewed clinical literature, device registries, regulatory filings, and procedural guidelines to validate technical performance claims and long-term safety signals.

Secondary research encompassed public policy documents, trade data, and clinical practice recommendations to model the interaction between regulatory changes, tariff effects, and adoption patterns. Data triangulation was applied to reconcile divergent viewpoints and to ensure that conclusions are grounded in multiple independent sources. Quality assurance procedures included cross-validation of interview transcripts, methodological audits of evidence selection, and internal peer review by clinical and market-access experts. Limitations were acknowledged where evidence gaps exist, particularly in newer material pairings and emerging minimally invasive techniques that lack long-duration outcome data.

Overall, the methodology balanced depth of clinical insight with breadth of commercial intelligence, enabling robust, actionable conclusions while transparently documenting assumptions and evidence sources.

Synthesis of strategic priorities and risk considerations that executives must align to convert innovation into measurable clinical and commercial outcomes

The convergence of demographic demand, materials and surgical innovation, and shifting care-delivery models positions the hip implant sector at an inflection point that rewards strategic foresight. Clinical advances and digital enablement create opportunities to improve patient outcomes and operational efficiency, but they also raise the bar for evidence generation, supply-chain agility, and commercial alignment with payers. Tariff-related cost pressures and regional regulatory complexity further emphasize the need for adaptable manufacturing footprints and proactive trade compliance.

Stakeholders that integrate clinical, commercial, and operational strategies will be best positioned to capture sustained value. This requires prioritizing robust clinical evidence, investing in surgeon training and digital planning tools, diversifying supply chains, and engaging payers in value-based arrangements. By applying these principles, manufacturers can not only protect margins but also expand access through demonstrable outcomes and flexible commercial models, while providers can optimize care pathways that deliver improved recovery and cost-effectiveness.

Taken together, the sector's near-term trajectory will be determined by the speed at which organizations translate innovation into validated clinical benefit and operational reliability, making coordinated cross-functional execution the defining capability for success.

Product Code: MRR-437E9896A56D

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven preoperative planning and predictive modeling to optimize hip replacement outcomes
  • 5.2. Growing demand for patient-specific 3D-printed hip implants to enhance anatomical fit and recovery
  • 5.3. Integration of robotic-assisted minimally invasive techniques for precise hip replacement procedures
  • 5.4. Expansion of outpatient hip replacement surgeries supported by advanced multimodal pain management
  • 5.5. Surge in development of bioactive implant coatings to accelerate osseointegration and reduce infection risk
  • 5.6. Rising adoption of modular dual mobility hip implant designs to minimize dislocation and improve stability
  • 5.7. Evolution of ceramic-on-ceramic and crosslinked polyethylene bearing surfaces to extend implant longevity
  • 5.8. Increasing use of telemedicine platforms for postoperative monitoring and personalized physical therapy adherence
  • 5.9. Strategic collaborations between implant manufacturers and research institutions to innovate advanced implant materials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Replacement Implant Market, by Surgical Approach

  • 8.1. Minimally Invasive
    • 8.1.1. Anterior Minimal
    • 8.1.2. Posterolateral Minimal
  • 8.2. Traditional
    • 8.2.1. Anterior Approach
    • 8.2.2. Posterior Approach

9. Hip Replacement Implant Market, by Fixation Method

  • 9.1. Cemented
  • 9.2. Cementless
  • 9.3. Hybrid

10. Hip Replacement Implant Market, by Material Pairing

  • 10.1. Ceramic on Ceramic
    • 10.1.1. Alumina on Alumina
    • 10.1.2. Zirconia on Zirconia
  • 10.2. Ceramic on Polyethylene
    • 10.2.1. Alumina on Polyethylene
    • 10.2.2. Zirconia on Polyethylene
  • 10.3. Metal on Metal
    • 10.3.1. Cobalt Chrome on Cobalt Chrome
    • 10.3.2. Titanium on Titanium
  • 10.4. Metal on Polyethylene
    • 10.4.1. Cobalt Chrome on Polyethylene
    • 10.4.2. Titanium on Polyethylene

11. Hip Replacement Implant Market, by Procedure Type

  • 11.1. Primary
    • 11.1.1. Bilateral
    • 11.1.2. Unilateral
  • 11.2. Revision
    • 11.2.1. Acetabular Revision
    • 11.2.2. Dual Revision
    • 11.2.3. Femoral Revision

12. Hip Replacement Implant Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Hip Replacement Implant Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Replacement Implant Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Replacement Implant Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. DePuy Synthes, Inc.
    • 16.3.2. Zimmer Biomet Holdings, Inc.
    • 16.3.3. Stryker Corporation
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Exactech, Inc.
    • 16.3.6. DJO Global, Inc.
    • 16.3.7. B. Braun Melsungen AG
    • 16.3.8. MicroPort Scientific Corporation
    • 16.3.9. Medacta International SA
    • 16.3.10. Corin Group PLC
Product Code: MRR-437E9896A56D

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HIP REPLACEMENT IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HIP REPLACEMENT IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HIP REPLACEMENT IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEM
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!